Model Can Predict Patient Outcomes to Immunotherapy, Engineer Proper Regimens

A clinically applicable mathematical model was developed by researchers to predict outcomes to immunotherapy for patients with cancer previously treated with anti –CTLA-4 or anti–PD-1/PD-L1 antibodies.

Source: CancerNetwork - May 11, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news